Oprozomib (PR-047) (ONX 0912) , an inhibitor for CT-L activity of 20S proteasome beta5(IC50=36 nM)/LMP7(IC50=82 nM), is orally bioavailable. Oprozomib also has potential antineoplastic activity.
Molecular Weight:
532.61
Purity:
98.00%
CAS Number:
[935888-69-0]
Formula:
C25H32N4O7S
Target:
Proteasome|||Apoptosis|||Autophagy
T6041
* VAT and and shipping costs not included. Errors and price changes excepted